AnteoTech Limited (ADO.AX)
AUD 0.01
(28.57%)
AUD 0.01
(28.57%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -11.72 Million AUD | 12.17% |
| 2023 | -13.35 Million AUD | -4.89% |
| 2022 | -12.72 Million AUD | -64.56% |
| 2021 | -7.73 Million AUD | -88.7% |
| 2020 | -4.09 Million AUD | -23.91% |
| 2019 | -3.3 Million AUD | -16.58% |
| 2018 | -2.83 Million AUD | -39.83% |
| 2017 | -2.02 Million AUD | 57.92% |
| 2016 | -4.82 Million AUD | 22.81% |
| 2015 | -6.24 Million AUD | -134.19% |
| 2014 | -2.66 Million AUD | 26.64% |
| 2013 | -3.63 Million AUD | -1.3% |
| 2012 | -3.58 Million AUD | -15.27% |
| 2011 | -3.11 Million AUD | -17.62% |
| 2010 | -2.64 Million AUD | -0.77% |
| 2009 | -2.62 Million AUD | 13.81% |
| 2008 | -3.04 Million AUD | 7.77% |
| 2007 | -3.3 Million AUD | -5.71% |
| 2006 | -3.12 Million AUD | -59.0% |
| 2005 | -1.96 Million AUD | 38.91% |
| 2004 | -3.21 Million AUD | 33.68% |
| 2003 | -4.85 Million AUD | 43.62% |
| 2002 | -8.6 Million AUD | -517.95% |
| 2001 | -1.39 Million AUD | -27.43% |
| 2000 | -1.09 Million AUD | -26906.87% |
| 1999 | 4078.00 AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -9.86 Million AUD | 0.0% |
| 2024 FY | -12.72 Million AUD | 4.71% |
| 2024 Q2 | -6.16 Million AUD | 0.0% |
| 2023 Q2 | -6.79 Million AUD | 0.0% |
| 2023 FY | -13.35 Million AUD | -4.89% |
| 2023 Q4 | -6.55 Million AUD | 0.0% |
| 2022 FY | -12.72 Million AUD | -64.56% |
| 2022 Q4 | -6.94 Million AUD | 0.0% |
| 2022 Q2 | -5.78 Million AUD | 0.0% |
| 2021 FY | -7.73 Million AUD | -88.7% |
| 2021 Q2 | -2.76 Million AUD | 0.0% |
| 2021 Q4 | -4.96 Million AUD | 0.0% |
| 2020 Q4 | -2.02 Million AUD | 0.0% |
| 2020 FY | -4.09 Million AUD | -23.91% |
| 2020 Q2 | -2.07 Million AUD | 0.0% |
| 2019 FY | -3.3 Million AUD | -16.58% |
| 2019 Q2 | -1.61 Million AUD | 0.0% |
| 2019 Q4 | -1.69 Million AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | -2.24 Million AUD | 0.0% |
| 2018 FY | -2.83 Million AUD | -39.83% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | -2.02 Million AUD | 57.92% |
| 2017 Q2 | -238.54 Thousand AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | -4.51 Million AUD | 0.0% |
| 2016 FY | -4.82 Million AUD | 22.81% |
| 2015 FY | -6.24 Million AUD | -134.19% |
| 2015 Q4 | -3.9 Million AUD | 0.0% |
| 2015 Q2 | -2.34 Million AUD | 0.0% |
| 2014 Q2 | -673.13 Thousand AUD | 0.0% |
| 2014 Q4 | -1.99 Million AUD | 0.0% |
| 2014 FY | -2.66 Million AUD | 26.64% |
| 2013 Q2 | -836.36 Thousand AUD | 3.91% |
| 2013 Q1 | -870.34 Thousand AUD | 0.0% |
| 2013 FY | -3.63 Million AUD | -1.3% |
| 2013 Q4 | -1.51 Million AUD | -72.09% |
| 2013 Q3 | -877.88 Thousand AUD | -4.97% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q2 | -870.34 Thousand AUD | -14.98% |
| 2012 Q1 | -756.98 Thousand AUD | 0.0% |
| 2012 FY | -3.58 Million AUD | -15.27% |
| 2012 Q3 | -870.34 Thousand AUD | 0.0% |
| 2011 Q3 | -756.98 Thousand AUD | 0.0% |
| 2011 FY | -3.11 Million AUD | -17.62% |
| 2011 Q2 | -756.98 Thousand AUD | -17.56% |
| 2011 Q1 | -643.91 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2010 Q2 | -643.91 Thousand AUD | -2.02% |
| 2010 Q3 | -643.91 Thousand AUD | 0.0% |
| 2010 FY | -2.64 Million AUD | -0.77% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q1 | -631.17 Thousand AUD | 0.0% |
| 2009 Q2 | -631.17 Thousand AUD | 12.9% |
| 2009 Q3 | -631.17 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q1 | -724.67 Thousand AUD | 0.0% |
| 2009 FY | -2.62 Million AUD | 13.81% |
| 2008 Q3 | -724.67 Thousand AUD | 0.0% |
| 2008 Q1 | -772.59 Thousand AUD | 0.0% |
| 2008 FY | -3.04 Million AUD | 7.77% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q2 | -724.67 Thousand AUD | 6.2% |
| 2007 FY | -3.3 Million AUD | -5.71% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 Q2 | -772.59 Thousand AUD | -12.51% |
| 2007 Q1 | -686.69 Thousand AUD | 0.0% |
| 2007 Q3 | -772.59 Thousand AUD | 0.0% |
| 2006 FY | -3.12 Million AUD | -59.0% |
| 2006 Q2 | -686.69 Thousand AUD | -55.5% |
| 2006 Q3 | -686.69 Thousand AUD | 0.0% |
| 2006 Q1 | -441.6 Thousand AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2005 Q3 | -441.6 Thousand AUD | 0.0% |
| 2005 Q1 | -804.79 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q2 | -441.6 Thousand AUD | 45.13% |
| 2005 FY | -1.96 Million AUD | 38.91% |
| 2004 Q3 | -804.79 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 FY | -3.21 Million AUD | 33.68% |
| 2004 Q1 | -1.1 Million AUD | 0.0% |
| 2004 Q2 | -804.79 Thousand AUD | 26.96% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q1 | -2.15 Million AUD | 0.0% |
| 2003 Q3 | -1.1 Million AUD | 0.0% |
| 2003 Q2 | -1.1 Million AUD | 48.8% |
| 2003 FY | -4.85 Million AUD | 43.62% |
| 2002 Q1 | -698.57 Thousand AUD | 0.0% |
| 2002 Q2 | -2.15 Million AUD | -208.06% |
| 2002 FY | -8.6 Million AUD | -517.95% |
| 2002 Q3 | -2.15 Million AUD | 0.0% |
| 2002 Q4 | - AUD | 100.0% |
| 2001 Q2 | -698.57 Thousand AUD | -155.61% |
| 2001 FY | -1.39 Million AUD | -27.43% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q3 | -698.57 Thousand AUD | 0.0% |
| 2001 Q1 | -273.29 Thousand AUD | 0.0% |
| 2000 Q1 | 1019.50 AUD | 0.0% |
| 2000 Q2 | -273.29 Thousand AUD | -26906.87% |
| 2000 Q3 | -273.29 Thousand AUD | 0.0% |
| 2000 Q4 | -273.29 Thousand AUD | 0.0% |
| 2000 FY | -1.09 Million AUD | -26906.87% |
| 1999 Q3 | 1019.50 AUD | 0.0% |
| 1999 FY | 4078.00 AUD | 0.0% |
| 1999 Q4 | 1019.50 AUD | 0.0% |
| 1999 Q2 | 1019.50 AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | -122.872% |
| Acrux Limited | -9.83 Million AUD | -19.246% |
| Actinogen Medical Limited | -12.83 Million AUD | 8.664% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -106.775% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -63.027% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -703.673% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 40.176% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -165.01% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -155.527% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -282.914% |
| Biome Australia Limited | -1.91 Million AUD | -512.919% |
| Biotron Limited | -5.15 Million AUD | -127.649% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 20.226% |
| BTC Health Limited | 1.05 Million AUD | 1211.224% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 4.737% |
| CSL Limited | 5.64 Billion AUD | 100.208% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 73.825% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 123.86% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -33.137% |
| Dimerix Limited | -25.05 Million AUD | 53.205% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 220.687% |
| Hexima Limited | -1 Million AUD | -1062.489% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -308.055% |
| Immuron Limited | -5.8 Million AUD | -102.144% |
| Immutep Limited | -44.93 Million AUD | 73.904% |
| Imugene Limited | -140.93 Million AUD | 91.679% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -449.609% |
| Memphasys Limited | -2.7 Million AUD | -333.676% |
| Nanollose Limited | -1.24 Million AUD | -838.26% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 105.19% |
| Noxopharm Limited | -7.53 Million AUD | -55.628% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -470.205% |
| Nyrada Inc. | -4.56 Million AUD | -157.144% |
| Orthocell Limited | -11.68 Million AUD | -0.389% |
| PharmAust Limited | -6.65 Million AUD | -76.111% |
| Patrys Limited | -3.53 Million AUD | -231.34% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 81.99% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -62.159% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -63.177% |
| PYC Therapeutics Limited | -38.85 Million AUD | 69.821% |
| Race Oncology Limited | -13.38 Million AUD | 12.361% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 75.161% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 46.821% |
| Starpharma Holdings Limited | -15.15 Million AUD | 22.643% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Tissue Repair Ltd | -4.87 Million AUD | -140.499% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -97.476% |